LoadingLoadingLoadingThe quick read
Latest quote·Oct 16
Net selling: insiders sold $30.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $30.7M and bought $0 of BJ stock on the open market in the 90 days to Oct 18, 2026, according to SEC Form 4 filings. $29.9M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Eddy, Robert W. (President & CEO), who sold $29M. The latest filing was on Oct 16, 2026.
None. No member of Congress disclosed a BJ trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 18, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (2)
AQR
$181.9M
added
D.E. Shaw
$91.6M
added
Sells/Trims (1)
Citadel
$141.6M
trimmed
Sells (3)
Felice Laura L.
$887K
sold
Eddy Robert W.
$19.7M
sold
Morningstar Timothy Pierce
$457K
sold
No tracked top-trader positions in BJ right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 21, 2026
Period ending
Jul 31, 2026
Earnings per share
$1.16 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Aug 21, 2026 | $1.36 / $1.16Alpha Vantage | +17.24% beat | Unavailable | Unavailable |
| Apr 30, 2026 | May 22, 2026 | $1.10 / $1.03Alpha Vantage | +6.80% beat | Unavailable | Unavailable |
| Jan 31, 2026 | Mar 5, 2026 | $0.96 / $0.93Alpha Vantage | +3.23% beat | Unavailable | Unavailable |
| Oct 31, 2025 | Nov 21, 2025 | $1.16 / $1.09Alpha Vantage | +6.42% beat | Unavailable | Unavailable |
| Jul 31, 2025 | Aug 22, 2025 | $1.14 / $1.09Alpha Vantage | +4.59% beat | Unavailable | Unavailable |
| Apr 30, 2025 | May 22, 2025 | $1.14 / $0.91Alpha Vantage | +25.27% beat | Unavailable | Unavailable |
| Jan 31, 2025 | Mar 6, 2025 | $0.93 / $0.87Alpha Vantage | +6.90% beat | Unavailable | Unavailable |
| Oct 31, 2024 | Nov 21, 2024 | $1.18 / $0.93Alpha Vantage | +26.88% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 17, 2026
EPS expected
$1.11 to $1.36
Revenue expected
18 analysts
Last 30 days
Analysts raising estimates
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.35B | $5.58B | $5.66B | $6.23B |
| Cost of what it sold | $4.33B | $4.57B | $4.63B | $5.12B |
| Gross profit | $1.01B | $1.01B | $1.03B | $1.11B |
| What it spent | ||||
| Sales and admin | $788.2M | $818.2M | $806.0M | $851.2M |
| Total operating expenses | $796.0M | $818.2M | $806.0M | $851.2M |
| What was left | ||||
| Operating profit | $218.4M | $191.4M | $221.9M | $258.8M |
| Interest on debt | $10.3M | $10.6M | $12.4M | $13.1M |
| Profit before tax | $215.9M | $167.5M | $195.5M | $239.3M |
| Tax | $63.8M | $41.6M | $52.8M | $65.4M |
| Net profit | $152.1M | $125.9M | $142.7M | $173.9M |
| EBITDA | $298.5M | $252.8M | $284.4M | $337.7M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
